Marco Carli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Bipolar Disorder

Ejection Fraction

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of environmental research and public health

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Letizia Biso, Stefano Aringhieri, Marco Carli, Marco Scarselli, Biancamaria Longoni
Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Letizia Biso, Stefano Aringhieri, Marco Carli, Marco Scarselli, Biancamaria Longoni
Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Letizia Biso, Marco Carli, Shivakumar Kolachalam, Giorgio Monticelli, Pasquale Fabio Calabrò, Antonello Di Paolo, Filippo Sean Giorgi, Guido Bocci, Marco Scarselli
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Irene Fasciani, Marco Carli, Francesco Petragnano, Francesco Colaianni, Gabriella Aloisi, Roberto Maggio, Marco Scarselli, Mario Rossi
GPCRs in Intracellular Compartments: New Targets for Drug Discovery. Biomolecules 12 (10) (2022)
Marco Carli, Eleonora Risaliti, Mena Francomano, Shivakumar Kolachalam, Biancamaria Longoni, Guido Bocci, Roberto Maggio, Marco Scarselli
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center. Pharmaceuticals (Basel, Switzerland) 15 (1) (2022)
Roberto Maggio, Irene Fasciani, Marco Carli, Francesco Petragnano, Francesco Marampon, Mario Rossi, Marco Scarselli
Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers. Biomolecules 11 (12) (2021)
Marco Carli, Francesca Vaglini, Eleonora Risaliti, Gianluca Citi, Matilde Masini, Shivakumar Kolachalam, Roberto Maggio, Giovanni Umberto Corsini, Michela Novelli, Vincenzo De Tata, Marco Scarselli
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA). Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Vincenza Spera, Alessandro Pallucchini, Marco Carli, Marco Maiello, Angelo G I Maremmani, Giulio Perugi, Icro Maremmani
Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture? Journal of clinical medicine 10 (7) (2021)
Alessandro Pallucchini, Marco Carli, Marco Scarselli, Icro Maremmani, Giulio Perugi
Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder. International journal of environmental research and public health 18 (3) (2021)
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, Anna Pintaudi, Marco Baldini, Stefano Aringhieri, Irene Fasciani, Paolo Annibale, Roberto Maggio, Marco Scarselli
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Alessandro Pallucchini, Marco Carli, Angelo Giovanni Icro Maremmani, Marco Scarselli, Giulio Perugi, Icro Maremmani
Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study. Journal of clinical medicine 10 (9) (2021)
Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, Francesco Marampon, Marco Carli, Marco Scarselli, Roberto Maggio, Mario Rossi
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Vincenza Spera, Alessandro Pallucchini, Marco Maiello, Marco Carli, Angelo G I Maremmani, Giulio Perugi, Icro Maremmani
Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features. International journal of environmental research and public health 17 (10) (2020)